Eclipsebio’s Posters

Scientists from Eclipsebio regularly present posters at conferences world-wide. Our studies involve the development of RNA genomics technologies and how they can accelerate tomorrow’s key RNA discoveries & medicines.

See Posters
image

eCLIP Validated Antibodies from Cell Signaling Technology

  • Eclipsebio has partnered with antibody provider, Cell Signaling Technology (CST), to present data demonstrating the importance of antibody validation and how using pre-validated eCLIP antibodies can expedite a successful eCLIP experiment

Enabling RNA Therapeutics and Manufacturing Quality Control

  • Read about the RNA genomics assays developed at Eclipsebio to enable and accelerate RNA drug development through detailed end-to-end analysis and characterization of RNA

Deep quantitative profiling of miRNA and siRNA targets using miR-eCLIP enrichment of sRNA:target chimeras

  • Building on the miR-eCLIP proof of concept to study direct targets of miRNAs, we are now exploring how this technology can be utilized to identify off-target interactions of siRNAs
  • miR-eCLP provides a snapshot of miRNA-target and siRNA off-target interactions that can both be useful for researchers studying the biology of these RNAs as well as for robust development of RNAi-based therapeutics

eCLIP Validated Antibodies from Cell Signaling Technology

  • Eclipsebio has partnered with antibody provider, Cell Signaling Technology (CST), to present data demonstrating the importance of antibody validation and how using pre-validated eCLIP antibodies can expedite a successful eCLIP experiment

Enabling RNA Therapeutics and Manufacturing Quality Control

  • Read about the RNA genomics assays developed at Eclipsebio to enable and accelerate RNA drug development through detailed end-to-end analysis and characterization of RNA

Deep quantitative profiling of miRNA and siRNA targets using miR-eCLIP enrichment of sRNA:target chimeras

  • Building on the miR-eCLIP proof of concept to study direct targets of miRNAs, we are now exploring how this technology can be utilized to identify off-target interactions of siRNAs
  • miR-eCLP provides a snapshot of miRNA-target and siRNA off-target interactions that can both be useful for researchers studying the biology of these RNAs as well as for robust development of RNAi-based therapeutics

Stay Updated with Our Upcoming Conferences & Events

Concluded Conferences

07
24
23

3rd mRNA-Based Therapeutics Summit

read more

Conferences

11
02
23

mRNA Assay Development Summit 2023

December 6-7, 2023
Boston, MA

read more